Related Experiment Videos
Membranous nephropathy: response to steroids and immunosuppression
American Journal of Nephrology
|January 1, 1981
Summary
Idiopathic membranous nephropathy treatment with prednisone showed benefits, with cyclophosphamide effective for non-responders. Prolonged therapy may be needed for remission in these kidney disease patients.
Area of Science:
- Nephrology
- Immunosuppressive Therapy
- Glomerular Diseases
Background:
- Idiopathic membranous nephropathy is a leading cause of nephrotic syndrome in adults.
- Understanding treatment efficacy is crucial for managing this kidney disease.
Purpose of the Study:
- To review the clinical course and treatment outcomes of adult patients with idiopathic membranous nephropathy.
- To evaluate the effectiveness of different immunosuppressive regimens.
Main Methods:
- Retrospective review of 23 adult patients with idiopathic membranous nephropathy.
- Analysis of treatment protocols including prednisone, cyclophosphamide, and azathioprine.
- Assessment of remission rates and renal function over up to 9 years.
Main Results:
- 95.7% of patients presented with nephrotic syndrome.
- Complete remission was achieved in 78.3% of patients, with most receiving prednisone-based therapy.
- Patients unresponsive to steroids showed improvement with added cyclophosphamide.
Conclusions:
- Prednisone appears beneficial for treating membranous nephropathy.
- Cyclophosphamide may be effective for steroid-refractory cases.
- Longer treatment durations may be necessary for achieving remission.